Skip to main content
. 2023 Jan 30;18(9):1884–1889. doi: 10.4103/1673-5374.367983

Figure 1.

Figure 1

Modeling neurodegenerative and psychiatric diseases with brain organoids.

The iPSCs are generated from the somatic cells of normal healthy controls and patients with a specific disease. Apart from the healthy iPSC control, the genetically corrected iPSCs from patients would help to avoid interference from the genetic background. Effective drug candidates need to be selected from the intersection of the two groups. iPSC: Induced pluripotent stem cell.